Skip to main content

St. Jude Medical to buy Thoratec in $3.4B deal

St. Jude Medical on Wednesday announced plans to acquire Thoratec in an all-cash deal valued at $63.50 a share or about $3.4 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.